| |
| |
|
| Insider
Information: |
Coffin Robert |
| Relationship: |
President & Chief R&D ... |
| City: |
Woburn |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,833,336 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$12,613,352 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,833,336 |
|
|
| Total
Value |
$12,613,352 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 36.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Replimune Group Inc |
REPL |
President & Chief R&D ... |
2023-05-16 |
1,833,336 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2023-05-16 |
4 |
S |
$18.05 |
$141,891 |
D/D |
(7,861) |
1,833,336 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2022-05-16 |
4 |
S |
$14.59 |
$83,703 |
D/D |
(5,737) |
1,796,197 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2022-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
26,250 |
1,801,934 |
0 |
- |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2021-07-02 |
4 |
AS |
$40.04 |
$312,712 |
D/D |
(7,810) |
1,775,684 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2021-06-29 |
4 |
AS |
$40.05 |
$914,181 |
D/D |
(22,826) |
1,783,494 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2021-06-28 |
4 |
AS |
$40.04 |
$587,107 |
D/D |
(14,663) |
1,806,320 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2021-01-22 |
4 |
AS |
$43.99 |
$2,665,973 |
D/D |
(60,000) |
1,744,118 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2020-12-22 |
4 |
AS |
$40.04 |
$8,808,800 |
D/D |
(220,000) |
1,804,118 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President & Chief R&D Officer |
• • – |
2020-07-09 |
4 |
AS |
$21.02 |
$3,757,295 |
D/D |
(169,750) |
2,024,118 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Pres & Chief Res & Dev Officer |
• • – |
2020-02-20 |
4 |
AS |
$17.04 |
$413,220 |
D/D |
(24,250) |
2,193,868 |
0 |
% |
|
| REPL |
Replimune Group Inc |
Pres & Chief Res & Dev Officer |
• • – |
2020-02-12 |
4 |
AS |
$17.03 |
$826,198 |
D/D |
(48,500) |
2,218,118 |
0 |
% |
|
| REPL |
Replimune Group Inc |
President and CEO |
• • – |
2019-11-06 |
4 |
AS |
$17.00 |
$824,985 |
D/D |
(48,500) |
2,266,618 |
0 |
- |
|
| REPL |
Replimune Group Inc |
President and CEO |
• • – |
2019-11-04 |
4 |
AS |
$17.00 |
$825,761 |
D/D |
(48,500) |
2,315,118 |
0 |
- |
|
| REPL |
Replimune Group Inc |
President and CEO |
• • – |
2019-10-31 |
4 |
AS |
$17.00 |
$412,250 |
D/D |
(24,250) |
2,363,618 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
